IPSEN BIOINNOVATION LIMITED
ActiveKey figures
† IPSEN BIOINNOVATION LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.
IPSEN BIOINNOVATION LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: IPSEN BIOINNOVATION LIMITED
What kind of company is it?
IPSEN BIOINNOVATION LIMITED is a private limited company registered with Companies House under company number 05480340. It was incorporated on 14 Jun 2005. Its status is active. The registered office is in London (W2). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Loss for the year was £342,000. Net assets were £1,529,000, up 0% on the previous year. Total assets were £2,996,000 and total liabilities £1,467,000. Figures are available for 2 financial years (2024–2025).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks higher than 84% of them (median £20,978). By total assets it ranks higher than 83% of them (median £125,654). It is older than 94% of them (median age 5.4 years).
Has it received government grants?
It is recorded as the recipient of 2 central government grants worth £33.1k, mainly from Department for Science, Innovation and Technology.
Who runs and controls the company?
One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 17 Oct 2027.
Filed accounts2024–2025
| 2024 † | 2025 † | |
|---|---|---|
| Profit for the year | -436,000 | -342,000 |
| Total assets | 3,094,000 | 2,996,000 |
| Total liabilities | 1,565,000 | 1,467,000 |
| Net assets / total equity | 1,529,000 | 1,529,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Government grants
2 grantsIPSEN BIOINNOVATION LIMITED is recorded as the recipient of 2 central government grants since 2020, together worth £33.1k.
- Department for Science, Innovation and Technology
- 1 grant · £26.3k
- Department for Business, Energy and Industrial Strategy
- 1 grant · £6,745
- Computational methods to predict stable biologics formulationsDepartment for Business, Energy and Industrial Strategy · £6,745 · UKRI - Innovate UK - Scheme 22/23
- Computational methods to predict stable biologics formulationsDepartment for Science, Innovation and Technology · £26,310 · UKRI - Innovate UK - Scheme
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
History
5 events- Financial year 2025 endedAccounts: net assets £1.5m
- Financial year 2024 endedAccounts: net assets £1.5m
- Ipsen Developments Limited registered as a person with significant control
- Name changed to IPSEN BIOINNOVATION LIMITEDPreviously SYNTAXIN LIMITED
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.